Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome.
Yongpeng GeSizhao LiShanshan LiLinrong HeXin LuGuochun WangPublished in: Therapeutic advances in chronic disease (2020)
Identifying anti-KS in patients with ILD may be useful for treatment, but reliable practical detection is needed. Furthermore, clinicians need to be aware of the possible presence of anti-KS antibodies in patients with ILD, either isolated or in combination with myositis.